Active Shortage

MYLAN-EFAVIRENZ

MYLAN PHARMACEUTICALS ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MYLAN-EFAVIRENZ in Canada?

Yes. MYLAN-EFAVIRENZ 600MG has an active shortage reported to Health Canada (last updated October 26, 2026).

Why is MYLAN-EFAVIRENZ not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will MYLAN-EFAVIRENZ be available again?

The manufacturer's estimated resolution date is July 13, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file1 product

Expected resolution~8 months remaining (estimate)

Affected strength600MG

Report last updated2026-10-26

Checked by MedShort2026-11-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

AURO-EFAVIRENZ

AURO PHARMA INC

600MG · DIN 02418428

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2027-07-13

~8 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02381524

Strength

600MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

EFAVIRENZ

Tier

Unrated

Last Updated

2026-10-26

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from MYLAN PHARMACEUTICALS ULC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

AZITHROMYCIN FOR INJECTION, USP

500MG · DIN 02385473

333MG · DIN 02293269

10MG · DIN 02257955

40MG · DIN 02257963

DIN 02388138

DIN 02388146